Hyperkeratosis and Palmoplantar Keratoderma Guidelines

Diagnosis and Evaluation

• Calluses develop as a direct hyperproliferative response of keratinocytes to continuing friction or pressure, appearing as hard, thickened, yellowish areas of skin, according to the British Journal of Dermatology 1
• If fever, headache, or systemic symptoms accompany palmar lesions with recent tick exposure, treatment with doxycycline for Rocky Mountain spotted fever should be initiated immediately, as recommended by the American Academy of Dermatology, with a mortality rate of 5-10% if untreated 2
• Pregnant patients with palmar pruritus require serum bile acid measurement to exclude intrahepatic cholestasis of pregnancy, which carries stillbirth risk, as per the American College of Obstetricians and Gynecologists 2

Dermatologic Conditions

• Palmoplantar psoriasis presents with well-demarcated erythematous plaques with thick silvery scale and hyperkeratosis, affecting 40% of psoriasis cases, according to the American Academy of Dermatology, and significantly impacting quality of life despite small body surface area involvement 3, 2
• Hyperkeratotic hand-foot eczema shows vesicles, scaling, erythema, and fissuring with yellow-white scaling, affecting 31% of cases, as reported by the American Academy of Dermatology 2

Treatment Algorithm

• Physical debridement with emery board or nail file can be used for self-management of mild hyperkeratosis, as recommended by the British Journal of Dermatology 1, 4
• The "soak and smear" technique, which involves soaking hands in plain water for 20 minutes and then applying moisturizer to damp skin, can enhance penetration and is recommended by the American Academy of Dermatology 2
• Initiate clobetasol propionate 0.05% cream or ointment twice daily to affected areas for inflammatory conditions like palmoplantar psoriasis or hyperkeratotic eczema, as per the American Academy of Dermatology 2
• Refer for topical PUVA (psoralen plus UVA) therapy 2-3 sessions weekly if no response after 4 weeks of topical therapy, achieving clearance in 58-81% of dyshidrotic eczema and 50-67% of hyperkeratotic eczema, as.Ptr the American Academy of Dermatology 2
• Initiate acitretin 25 mg daily for severe palmoplantar psoriasis, demonstrating significant improvement in scaling, thickness, and erythema within 2 months, as recommended by the American Academy of Dermatology 3, 2

Critical Pitfalls to Avoid

• Never dismiss fever with palmar rash as simple dermatitis—Rocky Mountain spotted fever mortality increases dramatically with delayed doxycycline treatment, as warned by the American Academy of Dermatology 2
• Avoid overdebridement of hyperkeratotic lesions, as this makes underlying skin susceptible to increased blistering and tenderness, particularly in fragile skin conditions, according to the British Journal of Dermatology 1, 4
• Quality of life impact from palmoplantar involvement is disproportionate to small body surface area affected, justifying systemic therapy when topical treatments fail, as reported by the American Academy of Dermatology 3

Treatment of Palmoplantar Keratoderma

First-Line Topical Management

• The British Association of Dermatologists recommends applying urea cream ≥10% once or twice daily for keratolysis, increasing concentration up to 40% for localized severe thickening on palms and soles 5
• Urea demonstrates superior safety compared to salicylic acid and lactic acid, with no reported toxicity cases in children, though high blood concentrations have been documented in neonates, so avoid in the first 6-12 months except on very limited areas 5
• The British Association of Dermatologists recommends tazarotene 0.05-0.1% as first-line topical retinoid to reduce scaling and skin thickening while avoiding systemic therapy, though availability may be limited due to cost and off-label use 5
• Topical isotretinoin 0.05-0.1% applied to less than 12% body surface has shown efficacy in clinical trials with mild side effects and no systemic exposure concerns 5

Physical Debridement Approach

• Self-management with emery board or nail file after soaking in warm water is appropriate for mild hyperkeratosis, as recommended by the British Association of Dermatologists 6
• Professional podiatric debridement with blade or scalpel is indicated when lesions are too painful or thick for self-management, according to the British Association of Dermatologists 6

Systemic Therapy for Severe Disease

• The British Association of Dermatologists recommends oral acitretin as the most effective treatment for severe palmoplantar keratoderma with marked hyperkeratosis, including Vohwinkel syndrome, keratitis-ichthyosis-deafness (KID) syndrome, hereditary punctate palmoplantar keratoderma, and Papillon-Lefèvre syndrome 7, 8, 9
• Evidence is based on small case series and anecdotal reports, but acitretin remains the most supported systemic option, as stated by the British Association of Dermatologists 7

Adjunctive Therapies

• Calcipotriol (vitamin D derivative) up to 100g per week showed moderate efficacy and good tolerability in adults with keratinization disorders, though pediatric data are limited, according to the British Association of Dermatologists 5
• Pressure redistribution and cushioning help prevent hyperkeratosis development, as recommended by the British Association of Dermatologists 6

Treatment Algorithm by Severity

• For mild disease, the British Association of Dermatologists recommends starting with urea ≥10% twice daily 5
• For moderate disease, escalate to urea 40% or add tazarotene 0.05-0.1%, and consider professional podiatric debridement as needed, according to the British Association of Dermatologists 5, 6
• For severe disease, initiate oral acitretin while continuing topical therapy, as recommended by the British Association of Dermatologists 7, 8, 9

Critical Clinical Pearls

• Salicylic acid and lactic acid are strictly contraindicated in children under 2 years due to life-threatening toxicity risk, as stated by the British Association of Dermatologists 5

Evidence‑Based Management of Acquired Diffuse Palmoplantar Keratoderma

Initial Assessment

• Baseline laboratory evaluation (CBC, liver function tests, and lipid panel) should be obtained before starting systemic therapy to identify contraindications and provide a reference for monitoring. – American Academy of Dermatology (moderate recommendation) 10

Systemic Therapy

• Oral acitretin 25 mg daily is the most effective systemic option for severe palmoplantar keratoderma, producing marked reduction in hyperkeratosis and fissuring within approximately 2 months. – American Academy of Dermatology (moderate evidence) 10

• After achieving disease control, the acitretin dose can often be tapered to 25 mg on alternate days while maintaining therapeutic benefit. – American Academy of Dermatology (expert opinion) 10

Monitoring & Safety

• Regular monitoring of lipids and liver enzymes is essential because oral acitretin can raise triglyceride and cholesterol levels and may affect hepatic function. – American Academy of Dermatology (moderate recommendation) 10

Treatment Duration

• Topical regimens generally require several months to achieve adequate clearance and to maintain disease control; patients should be counseled about the need for prolonged use. – American Academy of Dermatology (expert opinion) 10

• Systemic acitretin typically yields substantial clinical improvement within 2 months, but long‑term maintenance therapy is often necessary to prevent relapse. – American Academy of Dermatology (moderate evidence) 10

Safety Considerations & Pitfalls

• The disproportionate impact of palmoplantar disease on quality of life justifies escalation to systemic therapy when topical measures fail. – American Academy of Dermatology (moderate recommendation) 10

• Long‑term PUVA therapy carries an increased risk of skin cancer; the number of sessions should be minimized whenever possible. – American Academy of Dermatology (moderate recommendation) 10